Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06641895 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06641895 · ClinicalTrials.gov record · last posted 2025-03-25

Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy

Name: Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy — clinical trial record (NCT06641895)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseEarly Phase 1

SponsorShanghai Jiao Tong University School of Medicine

Started2024-07-25

View on ClinicalTrials.gov ↗

Record status

This record was last updated March 25, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

from the ClinicalTrials.gov record

The purpose of the study is to assess the safety, tolerability, and efficacy of BBM-D101 to treat patients with Duchenne Muscular Dystrophy.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2024-10-14. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details

NCT Number	NCT06641895
Lead Sponsor	Shanghai Jiao Tong University School of Medicine Collaborators: Shanghai Mianyi Biopharmaceutical Co., Ltd.
Conditions	Duchenne Muscular Dystrophy (DMD)
Enrollment	6 participants
Start Date	2024-07-25
Primary Completion	2026-07-31 (estimated)
Study Completion	2030-07-31 (estimated)
Updated on ClinicalTrials.gov	2025-03-25